SMU-pRMS: a novel cell line of pleomorphic rhabdomyosarcoma
Human Cell · 2025
DOI: 10.1007/s13577-025-01263-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2025. Verfasst von Naoya Nakahashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo- Ku, Sapporo, 060-8543, Japan. Hauptthemen laut MEDLINE: Rhabdomyosarcoma. Die Arbeit nennt 9 Literaturangaben. Gefördert von: KAKENHI, Sapporo Medical University Grants for Programs promoting Academic advancements, Akiyama Life Science Foundation.
Abstract (Originalsprache)
Pleomorphic rhabdomyosarcoma (pRMS) is a rare and highly malignant mesenchymal tumor. Complete resection is the only curative treatment available, owing to the limited efficacy of chemotherapy and radiotherapy. Therefore, developing novel therapies for pRMS is important for improving clinical outcomes. Herein, a novel pRMS cell line, SMU-pRMS, was established for a detailed understanding of the biological characteristics of pRMS, thereby developing new therapies. A tissue sample from a surgically resected tumor of a 69-year-old patient was subjected to primary culture. The cell line was established and authenticated by evaluating the short tandem repeats of DNA microsatellites. Monolayer cultures of SMU-pRMS cells exhibited constant growth, spheroid formation, and invasiveness. These cells exhibited high chemosensitivity to eribulin. In addition, mice inoculated with SMU-pRMS cells developed tumors after 4 weeks. Therefore, the SMU-pRMS cell line is a useful tool for investigating pRMS development and evaluating novel therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo- Ku, Sapporo, 060-8543, Japan.
- Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo- Ku, Sapporo, 060-8543, Japan. emrmkt@yahoo.co.jp.
- Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Departments of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Sapporo-Minami Orthopedic Hospital, 4-11 South 33 West 11, Minami-Ku, Sapporo, Japan.
Förderung
- KAKENHI
- Sapporo Medical University Grants for Programs promoting Academic advancements
- Akiyama Life Science Foundation
Zitieren
APA
Nakahashi, N., Emori, M., Murahashi, Y., Murase, K., Shimizu, J., Murata, K., Tsukahara, T., Sugita, S., Iba, K., Takada, K., Osanai, M., & Teramoto, A. (2025). SMU-pRMS: a novel cell line of pleomorphic rhabdomyosarcoma. Human Cell. https://doi.org/10.1007/s13577-025-01263-2
Vancouver
Nakahashi N, Emori M, Murahashi Y, Murase K, Shimizu J, Murata K, et al. SMU-pRMS: a novel cell line of pleomorphic rhabdomyosarcoma. Human Cell. 2025. doi:10.1007/s13577-025-01263-2
BibTeX
@article{Nakahashi2025,
author = {Nakahashi, Naoya and Emori, Makoto and Murahashi, Yasutaka and Murase, Kazuyuki and Shimizu, Junya and Murata, Kenji and Tsukahara, Tomohide and Sugita, Shintaro and Iba, Kousuke and Takada, Kohichi and Osanai, Makoto and Teramoto, Atsushi},
title = {SMU-pRMS: a novel cell line of pleomorphic rhabdomyosarcoma},
journal = {Human Cell},
year = {2025},
doi = {10.1007/s13577-025-01263-2}
}
EUVIMED